Genzyme Selects Automsoft's RAPID-Pharma in Global Deal RAPID-Pharma to be deployed across Genzyme Therapeutics Manufacturing sites
August 20th, 2003, Princeton, New Jersey - Automsoft, the leading global provider of advanced database software designed specifically to manage production data for process industries in a secure environment, today announced a multi-million dollar deal with Genzyme Corporation. Genzyme, a leading biotechnology company, is deploying Automsoft's RAPID-Pharma across its primary therapeutic manufacturing sites. Genzyme will use RAPID-Pharma to manage its production environment. RAPID-Pharma will be responsible for all data capture; all process and plant information necessary for reporting and analyzing activities and trends will be derived through it. RAPID-Pharma is also being deployed to bring the facilities into compliance with the FDA's 21 CFR Part 11 ruling.
Phillip Maderia, Associate Director, Automation Engineering for Genzyme, said,"Genzyme selected Automsoft because of its overall competence in providing real-time visibility of the production environment. The RAPID-Pharma data management system meets our requirements for Part 11 compliance, unparalleled ease of use and delivers functionality that allows us to control and manage our production environment. In short, RAPID-Pharma will help us to optimize our processes, create consistency while minimizing losses." "Automsoft's technology gives our customers unprecedented visibility of their manufacturing operations. The kind of intelligence that RAPID-Pharma delivers empowers manufacturers to overcome the critical issues facing them today.
For the pharmaceutical industry these are predictability, consistency in their processes and compliance with FDA regulations," said Paraic O'Toole, CEO of Automsoft. "We are very pleased that we can provide these capabilities to Genzyme and confident that RAPID-Pharma will be a very valuable tool to them." About GenzymeGenzyme Corporation is a global biotechnology company dedicated to making a major positive impact on the lives of people with serious diseases. More than 5,000 Genzyme employees in offices around the globe serve patients in over 80 countries. About Automsoft Automsoft is the leading global provider of advanced database software, designed specifically to manage production data for process industries in a highly secure environment.
The company's core product suite, RAPID(tm), allows manufacturers to collect, store, analyze and report on production data, bridging islands of information throughout the plant. By providing one true and reliable picture of the manufacturing process, RAPID becomes a powerful business tool helping to improve production quality, reduce costs and meet regulatory requirements. RAPID's industry-specific software helps to optimize the production process for gas and oil, food and beverage, pharmaceutical, chemical and utilities industries. RAPID-Pharma, designed specifically for the pharmaceutical sector, is operating in eight of the world's top 20 pharmaceutical companies and complies with the FDA's 21 CFR Part 11 regulation on Electronic Records and Electronic Signatures.
Founded in 1997, Automsoft is located in Princeton, New Jersey and Dublin, Ireland, and has sales offices in the UK and Germany. Automsoft has customers in North America, Scandinavia, UK, Ireland, Switzerland, Germany, Netherlands and Belgium. Automsoft is a member of the OPC Foundation and ISPE, and works with a global network of partners.
For further information, please visit www.automsoft.com
